Panacea Global Inc. (PINK:PANG)

Panacea Global, Inc., a biopharmaceutical company, provides blood, serum, and tissue tests to diagnose and monitor cancer. The company holds the rights to various human aspartyl asparaginyl hydroxylase (HAAH) based cancer diagnostic tests outside the United States. Its laboratories offer various tests, including BC Detect that aids in the detection of recurrence of breast cancer; CC Detect, which aids in the detection of colorectal cancer; LC Detect that aids in the detection of lung cancer; PC Detect for prostate cancer; and TK Sense, a gene expression test that predicts the response of patients with Chronic Myelogenous Leukemia to imatinib. The company is based in Richmond Hill, Canada. Panacea Global, Inc. is a subsidiary of Moneylogix Group, Inc.